Extended Data Fig. 4: Kaplan Meier curves for progression-free survival of intracranial lesions as per RANO-BM criteria (A), and extracranial (B) and overall lesions (C) as per RECIST v1.1 criteria for patients with breast and lung cancers. | Nature Medicine

Extended Data Fig. 4: Kaplan Meier curves for progression-free survival of intracranial lesions as per RANO-BM criteria (A), and extracranial (B) and overall lesions (C) as per RECIST v1.1 criteria for patients with breast and lung cancers.

From: Patritumab deruxtecan in leptomeningeal metastatic disease of solid tumors: the phase 2 TUXEDO-3 trial

Extended Data Fig. 4

Shaded areas represent 95% CI. CI: Confidence interval, mPFS: median progression-free survival, NA: Not achieved, PFS: Progression-free survival.

Back to article page